Guanine-nucleotide exchange factors (GEFs) stimulate the intrinsic GDP/GTP exchange activity of Ras and promote the formation of active Ras-GTP, which in turn controls diverse signalling networks important for the regulation of cell proliferation, survival, differentiation, vesicular trafficking, and gene expression. RasGEF1b is a GEF, whose expression is induced in macrophages on stimulation with toll-like receptor (TLR) agonists. Here, we showed that in vitro RasGEF1b expression by macrophages is mostly induced by TLR3 (poly I:C) and TLR4 (lipopolysaccharyde) through the MyD88-independent pathway. In vivo infection with the protozoan parasites Trypanosoma cruzi and Plasmodium chabaudi induced RasGEF1b in an MyD88-, TRIF-, and IFN-g-dependent manner. Ectopically expressed RasGEF1b was found, mostly, in the heavy membrane fraction of HEK 293T, and by confocal microscopy, it was found to be located at early endosomes. Computational modelling of the RasGEF1b-Ras interaction revealed that RasGEF1b interacts with the binding domain site of Ras, a critical region for interacting with GEFs involved in the activation of Ras-Raf-MEK-ERK pathway. More important, RasGEF1b was found to be closely associated with Ras in live cells and to trigger Ras activity. Altogether, these results indicate that on TLR activation, RasGEF1b may trigger Ras-like proteins and regulate specific biological activities described for this subtype of GTPases.
Introduction
The innate immune system is the first line of defence that protects host from invasion of microbial pathogens. Host cells express various pattern recognition receptors that sense diverse pathogen-associated molecular patterns, including glycolipids, lipoproteins, proteins, and nucleic acids. In mammals, the family of toll-like receptors (TLR) expressed in antigen-presenting cells serves as key pattern recognition receptors with central function in the induction of innate immune response as well as the subsequent development of adaptive immune response. 1 Recognition of pathogen-associated molecular patterns by TLRs stimulates the recruitment of intracellular TIRdomain-containing adaptors, including MyD88, MAL/ TIRAP, TRIF, and TRAM through TIR-TIR interactions, which leads to the activation of many signalling pathways. 2 Ras proteins are the founding members of a large superfamily of small GTPases composed of B150 human members that function as regulated GDP/GTP molecular switches that control diverse signalling networks important for the regulation of cell proliferation, survival, differentiation, actin organization, vesicular trafficking, and gene expression. On the basis of the sequence and functional similarities, the family is divided into at least five distinct branches: Ras, Rho, Rab, Arf, and Ran. 3 Guanine-nucleotide exchange factors (GEFs) stimulate the intrinsic GDP/GTP exchange activity of Ras and promote the formation of active Ras-GTP, whereas GTPase-activating proteins (GAPs) stimulate the slow intrinsic GTP hydrolysis activity of Ras to promote formation of inactive Ras-GDP. 3 All RasGEFs have a common B250 amino-acid CDC25 homology catalytic domain (also called RasGEF domain) and an adjacent B50 amino-acid amino-terminal Ras exchange motif (also called RasGEFN domain). 4 RasGEF1b, first called glycosilphosphatidilinositol (GPI)g4, is a GEF, whose expression is strongly induced in murine macrophages on stimulation by TLR2 and TLR4 agonists and in heart from mice infected with Trypanosoma cruzi. As in mice, RasGEF1b expression is induced in human macrophages on stimulation with GPI-mucin or lipopolysaccharyde (LPS). 5 The RasGEF1b protein contains two domains, an RasGEFN and an RasGEF domains, encoded by amino-acids 40-138 and 201-455, respectively. Although its homology to GEFs of the Ras subfamily points towards a function in the activation of these GTPases, the catalytic activity and binding specificity to Ras remain to be determined.
In this study, we show that RasGEF1b, but neither RasGEF1a nor RasGEF1c, is expressed in murine macrophages stimulated with LPS. Our results obtained in vitro also point out that RasGEF1b expression in murine macrophages is primarily stimulated by TLR agonists that activate TRIF (that is LPS and poly I:C). In vivo in mice infected with T. cruzi or Plasmodium chabaudi, induced expression of RasGEF1b required both functional MyD88 and TRIF. When over-expressed, ectopic RasGEF1b was found to be mainly located at heavy membranes (HMs), and by confocal microscopy, we determined the early endosomes as its main location site. Computational modelling analysis shows that the cdc25 domain of RasGEF1b closely resembles that of son ofsevenless (Sos) 6, 7 and is very likely to interact with Ras. Consistently, we provide evidences indicating that RasGEF1b interacts with Ras in higher eukaryotic cells. Thus, we show that ectopically expressed RasGEF1b colocalizes with endogenous Ras and is capable of triggering Ras activity in 293T cells. In conclusion, this study provides new information about the potential function of RasGEF1b in mediating Ras-associated activities triggered by TLR activation.
Results
Expression of RasGEF1b, but neither RasGEF1a nor RasGEF1c, is induced in inflammatory macrophages exposed to LPS The RasGEF1 family is composed of three members: RasGEF1a, RasGEF1b, and RasGEF1c, which are present in both human and mouse genomes (Supplementary Figure 1A) . The RasGEF1b cDNA sequence is predicted to encode two GEF motifs and is highly conserved in phylogenic distant vertebrate species (Supplementary Figures 1B and C) . One domain is located at the aminoterminal domain with a potential structural function and named GEF-N and the other at the COOH terminus resembling a cdc25-related catalytic domain. 5 Alignment of the amino-acid sequences containing the GEF-N and cdc25 homology domains of murine, human, chicken, Xenopus, and fish RasGEF1b (Supplementary Figure 1B) indicated a high degree of sequence similarity. The Cdc25 homology domain boundaries are assigned based on the minimal active domain described for Sos. RasGEF1b was originally identified as a gene, whose expression is strongly induced by macrophages exposed to GPIs anchors from T. cruzi, 5 known as a TLR2 agonist. 8 It has been also described that RasGEF1a is constitutively expressed in human brain tissue. 9 We first asked whether RasGEF1a and RasGEF1c were also expressed in murine macrophages stimulated with TLR agonists. Inflammatory macrophages were treated with LPS or medium alone, and the total RNA extracted. RasGEF1a, RasGEF1b, and RasGEF1c gene expression was then analysed by RT-PCR. The results presented in Figure 1a show that only RasGEF1b, but neither RasGEF1a nor RasGEF1c expression, is induced in murine macrophages stimulated with LPS. As positive controls for RasGEF1a and RasGEF1c, we performed RT-PCR using total RNA extracted from brain tissue of C57BL/6 mice. As earlier reported for RasGEF1b, 5 we observed a robust and constitutive expression of both RasGEF1a and RasGEF1c mRNA in murine brain tissue (Figure 1a) . Similar findings were obtained in microarray analysis, performed elsewhere for expression of rodent RasGEF1b, 1a, and 1c in different tissues and cells (http://biogps.gnf.org/).
TRIF-induced expression of RasGEF1b in macrophages exposed to TLR3 (poly I:C) and TLR4 (LPS) agonists Our earlier study showed that either TLR2 (GPIs) or TLR4 (LPS) agonists were able to induce expression of RasGEF1b mRNA by murine macrophages. 5 The expression of RasGEF1b induced by parasite GPIs was relatively small, but greatly enhanced when macrophages were primed with IFN-g. To determine the importance of the different TLR adaptor molecules on RasGEF1b mRNA expression, we stimulated inflammatory murine macrophages with different TLR agonists, that is CpG ODN, LPS, poly I:C, and Pam3cys, and then RasGEF1b expression was determined by RT-PCR. In addition, we used macrophages from knockout mice lacking functional MAL/TIRAP, TRIF, or MyD88. The results presented in Figure 1b show that RasGEF1b expression is strongly induced by LPS (TLR4 agonist) or poly I:C (TLR3 agonist), and to a much lesser extent by CpG ODN (TLR9 agonist) or Pam3cys (TLR2 agonist). The results presented in Supplementary Figure 2 show that RasGEF1b mRNA induced by LPS or poly I:C peaked between 2 and 4 h post-stimulation, indicating that RasGEF1b is an early response gene.
Further, we present evidences that NF-kB may be involved on induction of RasGEF1b gene expression triggered by TRIF, as the ability of poly I:C to trigger RasGEF1b mRNA expression was highly inhibited by TPCK (Supplementary Figure 2b) . Furthermore, our idea is strongly supported by the result (Supplementary Figure 3) , as bone marrow macrophages are obtained from mice lacking functional type I interferon receptor and stimulated by LPS express RasGEF1b at the same level of wild-type mice. Depending on the TLR agonist used, deficiency of all adaptor proteins, that is MAL/ TIRAP (for TLR2 agonist), MyD88 (for TLR2, TLR4, and TLR9 agonists), and TRIF (for TLR3 and TLR4 agonists), had a negative impact on RasGEF1b expression (Figure 1b) . It is noteworthy, however, that for TLR4, which uses all three adaptors, the lack of TRIF had the most profound effect on RasGEF1b mRNA expression. Further, activation of TLR3, which uses TRIF only, induced high expression of RasGEF1b mRNA. Together, these findings suggest that the TRIF pathway is the main one involved on induction of RasGEF1b expression by TLR agonists, although MyD88 is also important.
We then infected C57BL/6, IFN-g-/-, MyD88-/-, and TRIF-/-mice with T. cruzi or P. chabaudi, and evaluated RasGEF1b expression in the spleens by RT-PCR. Our results show that RasGEF1b expression is induced by infection with T. cruzi or P. chabaudi, and in vivo this expression seems to be IFN-g, MyD88, and TRIF dependent (Figure 1c ).
RasGEF1b native protein is induced in murine macrophages exposed to LPS To explore the expression of RasGEF1b protein in cells, peritoneal macrophages from mice were plated and treated with LPS (1 mg ml -1 ) for different periods (0, 6, 12, 18, and 24 h). Cells were lysed in 10 mM KCl buffer and whole cell extracts (30 mg) electrophoresed in a 12% acrylamide gel under denaturing conditions, transferred to nitrocellulose membrane and immunoprobed with rabbit polyclonal antibodies raised against His6-RasGEF1b. Through analyses of its mRNA sequence (gene bank accession no. AY129963), 5 we identified a putative open reading frame that encodes 473 amino acids, resulting in a polypeptide with predicted molecular mass of RasGEF1b protein to 55 kDa. Using the recombinant RasGEF1b, we raised a polyclonal antibody in rabbit, which preferentially recognizes the NH 2 -terminus domain of RasGEF1b ( Figure 2a ). As shown in Figure 2b , RasGEF1b expression was maximal at 12 and 18 h poststimulation with LPS. Cell extracts of murine macrophages were then fractionated onto a bi-dimensional electrophoresis, transferred to a PVDF membrane and immunoblotting performed using the anti-His6Ras-GEF1b antibody. Our results show colloidal coomassie blue staining (Figure 2c, upper) , and a spot within circle recognized by the anti-His6-RasGEF1b antibody . Analysis was performed with total RNA obtained from mice spleen after T. cruzi (18 days) or P. chabaudi (6 days) pos-infection. One microgram of total RNA derived from each sample was used to obtain the first strand cDNA, which was used as template in PCR reactions to amplify cDNA fragments corresponding to RasGEF1a, RasGEF1b, RasGEF1c, IFN-b, or GAPDH mRNAs. PCR products were fractionated onto 1.2% agarose gel, stained with ethidium bromide, visualized in UV transiluminator, and the images captured by a CCD camera.
( Figure 2c , lower). The protein recognized has molecular mass expected for endogenous RasGEF1b and isoeletric point close to the one predicted for the endogenous RasGEF1b, pI of 8.19.
Cloning, expression, and subcellular localization of RasGEF1b in mammal cells
The first AUG initiation codon in the 1419 nucleotides of RasGEF1b mRNA sequence does not meet Kozak's translation initiation criteria, as the þ 4 position is found as a C, instead of a G. To gain insights on the physiological function of RasGEF1b in cells, we cloned its cDNA coding sequence in a eukaryotic vector with a FLAG epitope containing the optimal Kozak's consensus at its NH2 terminus, as well as in fusion with the fluorescent proteins mRFP and YFP. As shown in Figure 3a , 293T cells transfected with RasGEF1b-YFP, presented localized expression of chimeric protein, whereas cell transfected with plasmid containing only YFP gene, expressed recombinant YFP in whole cell cytoplasm as expected. 10 After transfections with pFLAG-RasGEF1b, but not transfection with vector alone (pcDNA3.1), HEK 293T cells expressed a 56-kDa protein specifically recognized by the monoclonal anti-FLAG M2 antibody. The level of expression of RasGEF1b for the similar amounts of transfected plasmid was comparable ) for a different stimulation times (0, 6, 12, 18, and 24 h). Cells were lysed in 10 mM KCl buffer and whole cell extracts (30 mg) were electrophoresed in a 12% acrylamide gel under denaturing conditions and transferred to nitrocellulose membrane and immunoprobed with rabbit polyclonal anti-His6RasGEF1b. RasGEF1b-YFP was used as a positive control. (c) Two-dimensional electrophoresis analysis of murine macrophages whole cell extracts. The orientation of pH gradient of the gels is no linear from 7 to 11 (left to right). The samples were separated in first dimension on 7 cm IEF strip followed by a second-dimension fractionation onto 12% SDS-PAGE. Relative molecular masses are indicated on the left (kDa). Colloidal coomassie staining (upper) and western blotting with anti-His6RasGEF1b (lower) are shown. The spot within circle indicates endogenous RasGEF1b recognized by the antibody. with TAK1 and MAL/TIRAP, both containing FLAG epitope at their NH2 terminus and under regulation of a CMV promoter (Figure 3b) .
Activation of small GTPases Ras requires the participation of GEFs, which induces the dissociation of GDP to allow association of the more abundant cytosolic GTP. 11 A number of RasGEFs have been characterized. 4, 12 Sos1, and Sos2, for example, are normally localized in the cytosol, but in response to extracellular stimulation, they are recruited to the plasma membrane. Through preliminary analysis of cellular distribution, we carried out subcellular fractionation studies, in which we could precisely show that RasGEF1b is predominantly localized at HMs (Figure 3c; Supplementary Figure 4) . The western blot results depicted in Figure 3c also suggest that RasGEF1b may be localized at the nucleus and at light membranes. The latter localization seems to be real, as calreticulin, which is predominantly localized at HM, is not detected at light membranes, supporting the hypothesis that RasGEF1b may shuttle among cell organelles.
Ectopic RasGEF1b is located at early endosome Ras acts as a molecular switch of a wide variety of signalling pathways that direct cell cycle progression, survival, and differentiation depending on cell types. Ras is activated by various GEFs, in response to signals triggered by various membrane-spanning receptors. [13] [14] [15] Different cellular localization (for example plasma membrane, endoplasmic reticulum (ER), or Golgi apparatus) of Ras proteins controls the proximity to different types of GEFs, which in turn results in differences in susceptibility to activation by particular stimuli. 16 To determine its cellular localization, RasGEF1b cDNA was cloned in fusion with fluorescent proteins mRFP or YFP. CHO cells were transfected with the constructs and by confocal microscopy, we show that RasGEF1b is primarily located at early endosome. In the results presented in Figure 4a , we show that expression of ectopic RasGEF1b does not localize with ER marker. Importantly, we observed a partial and highly significant co-localization of RasGEF1b with endolysosome (LysoTracker) (Figure 4b ). To further address the issue of RasGEF1b localization, we used antibodies specific for EEA1, an early endosome marker. Our results show a significant overlap of EEA1 and RasGEF1b, suggesting that a main localization of RasGEF1b occurs at the level of early endosomes (Figure 4c ). Further, we observed no colocalization of ectopic RasGEF1b and LAMP-1, a lysosome marker 17 (Supplementary Figure 5) , suggesting that RasGEF1b may shuttle between early and late endosomes.
RasGEF1b interacts with and activates endogenous Ras/p21 isoforms in cells
It is well known that after cellular activation, GEFs must be found in some cellular compartments in which their cognate GTPases are located. For example, Ras is localized to the inner leaflet of the plasma membrane, and so this localization is necessary for it to signal. Depending on the post-translational modification, Ras isoforms can be located in different organelles, as ER. 11 Using a computational modelling of Ras and Sos interaction, we determined that RasGEF1b cdc25 domain overlaps that of Sos in the Ras interaction (Figures 5a-d) . Importantly, the Ramachandram plot (Figure 5e ) supported our findings, showing that after these models, 87.5% of all residues of RasGEF1b are in the most favoured regions and 0.2% of residues are in disallowed regions. This observation indicates that this interaction based on in the computational modelling shown in Figure 5b most likely occurs through a specific domain present in RasGEF1b. We then reasoned whether RasGEF1b could be found associated with Ras in cells. To test this, CHO cells were transfected with a plasmid coding RasGEF1b-mRFP and fixed with 4% paraformaldehyde and stained using primary antibody anti-Ras clone 10, which stain p21 H, K, and N-Ras. 18 Analysis using confocal microscopy ( Figure 6a) shows that RasGEF1b-mRFP co-localize with endogenous Ras in CHO cells. Further, HEK 293T cells were transiently transfected with a plasmid coding increasing amounts of pFLAG-RasGEF1b, and immunoprecipitation analysis of these cell extracts using anti-pan Ras antibody revealed that RasGEF1b, but not MKK6 (not shown), has specific affinity for endogenous Ras (Figure 6b ). To evaluate whether ectopic RasGEF1b is capable to activate Ras, we performed a Ras activation assay using cell lysates of 293T cells 24 h after transfection with RasGEF1b-mRFP or pFLAGRasGEF1b. Both proteins were capable to activate Ras in vitro (Figure 6c ).
Discussion
Ras proteins functions are regulated by GDP/GTP molecular switches that control diverse signalling networks important for the regulation of cell survival, proliferation, differentiation, vesicular trafficking, and gene expression. 3 GEFs activate Ras proteins through one or more catalytic domains homologous with the minimal Ras activation domain from CDC25, yeast GEF that activates Saccharomyces cerevisiae Ras. 19 The crystallographic structure of the interaction of the CDC25 domain of Sos1 and H-Ras has revealed the details of this interaction. 7 GEFs exhibit a large range of additional structural features that enable them to respond to many different signals. These signals include the phosphorylation of proteins and lipids, calcium fluxes, and the generation of cyclic nucleotides or diacylglycerol. [20] [21] [22] [23] In the structure of RasGEF1b exists two main domains: one for interaction with Ras (RasGEFN) and one cdc25-like domain spanning the region of amino acid at position 204 through 448, 5 which may be essential for full GEF catalytic activity. Among its functions, it is likely that RasGEF1b gene is a signalling component expressed during the immune response, as expression of RasGEF1b mRNA is enhanced in vitro in macrophages activated with TLR agonist or in activated T cells, as well as in vivo in animals that received microbial challenge. 5 In this study, we established that RasGEF1b, but neither RasGEF1a nor RasGEF1c, expression is induced by LPS in murine macrophages. Importantly, TLR agonists that activate the TRIF pathway (that is LPS and poly I:C) were the most potent inducers of RasGEF1b expression. Importantly, by using an antiRasGEF1b polyclonal antibody, we detected the presence of native RasGEF1b protein in the extracts from macrophages exposed to LPS. Further, we cloned the RasGEF1b gene into plasmids in frame with a pFLAG, mRFP, or YFP tags, and transfected HEK and CHO mammalian cell lines to define RasGEF1b expression. Number of non-glycine and non-proline residues 416 100.0%
Number of end-residues (excl. Gly and pro) 2 Number of glycine residues (shown as triangles) 13 Number of proline residues 17
Total number of residues 448
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms and R-factor no greater than 20%, a good quality model would be expected to have over 90% in the most favoured regions. RasGEF1b interacts with Ras, and showing that RasGEF1b binds to endogenous Ras in 293T cells and is capable to trigger its activity. There are few reports about RasGEF1a and RasGEF1b expression. It has been shown that RasGEF1a expression is increased in the majority of intra-hepatic cholangiocarcinoma and that its inhibition reduces cell growth. 9 The family of E2F transcription factors regulates a number of cellular functions including apoptosis and cell differentiation, and it was seen that E2F1 induces activation of ERK and expression of RasGEF1b in vitro in mammalian cells. 24 In zebrafish, RasGEF1b expression occurs during embrionary development and is tightly regulated. 25 We show that in addition to RasGEF1a, RasGEF1c is also highly expressed in mouse brain.
We further showed that RasGEF1b, but neither RasGEF1a nor RasGEF1c, expression is strongly induced by LPS and poly I:C, and to a much less extend by CpG ODN and Pam3cys. Consistently, TRIF deficiency completely and partially abrogated the poly I:C and LPSinduced RasGEF1b mRNA expression, respectively. In the case of LPS response, and other TLR agonist that do not activate the TRIF pathway, MyD88 was also important to mediate the induction of RasGEF1b mRNA expression. In vivo, RasGEF1b expression was induced in mice infected with T. cruzi or P. chabaudi and showed to be dependent on MyD88, TRIF, as well as IFN-g. The Vav family of Rho guanine-nucleotide factor was found to be important in MyD88-dependent reactive oxygen intermediates production and also essential for normal p38 MAPK activation and pro-inflammatory cytokine production. 26 Together, these results support the hypothesis that RasGEF1b expression is induced by the TRIF and MyD88 pathways, and mediates innate immune responses triggered during microbial infection.
To gain some insight on the RasGEF1b activity and function, we developed a system for expression of ectopic RasGEF1b tagged with pFLAG, YFP, or mRFP. RasGEF1b was found mostly in HM fraction of transfected cell lines, and by confocal microscopy, we identified RasGEF1b to be located at early endosome. When H-Ras and N-Ras are palmitoylated, they traffic to the plasma membrane along the secretory pathway through the Golgi complex. 27 It is well known that GEFs should be found in some cellular compartments where their cognate GTPases are located, so it is reasonable to speculate that RasGEF1b can be primarily located at early endosome to activate Ras during vesicular traffic to membrane, as endogenous Ras and unpalmitoylated H-Ras are activated in response to mitogens on the Golgi and ER, respectively. 28 In response to extracellular stimulation, such as a growth factor, GDP is released from Ras being activated by the subsequent binding of GTP, that is the guaninenucleotide exchange reaction. Such reaction is catalysed by the direct physical association between Ras and its respective GEF and seems to be essential for Ras-MEK-ERK pathway activation. Identifying the cellular components to which a GEF physically associates can give important clues to its functions. We have initiated the investigation of the involvement of RasGEF1b in Ras activation through over-expression in mammal cells. Ras was found to specifically interact with RasGEF1b in cells and was capable to activate it. This suggests that such interaction may regulate specific biological activities described to Ras. Rap family members are considered to be close homologues of Ras proteins, and their effector-interacting regions are very similar. 29 It was shown that RasGEF1B function as a guanine exchange factor for Rap2, a member of the Rap subfamily of Ras-like G-proteins. 30 Our experimental evidences are further supported by the computational modelling depicting RasGEF1b association with Ras. Structural and biochemical studies 7, 31, 32 have implicated both the switch I and switch II regions of Ras to be involved in the interaction with its GEF, Sos. In particular, the switch II region is held tightly by Sos through hydrophobic interactions surrounded by polar and charged contacts. On the basis of the computational modelling, we speculate that Ras likely interacts with RasGEF1b through hydrophobic amino acids.
At the same time that new GEFs are being discovered, it is becoming increasingly evident that the molecular mechanisms by which GEFs activate the small GTPase are as varied as their own GEFs, and the specificity between GEF and GTPase is more a question of location than the proper interaction. 27, 33 Some functions for GEFs in the immune system have been described. RasGRP is important to mouse thymocyte differentiation after TCR stimulation, 34 and members of Vav family are essential for response of B lymphocytes to LPS. 35 Numerous studies with tumour cell lines, such as Jurkat cells or EL4 mouse lymphoma cells, indicate that Ras represents an essential link between TCR stimulation and cellular proliferation or cytokine gene induction. 36 AKAP13, an anchoring protein, which has GEF activity, had its expression induced by TLR2 agonist Pam3cys, leading to activation of NF-kB and JNK and induction of pro-inflammatory cytokines. 37 It was shown that Ras signalling through TLR9 is in induction by CPG DNA in macrophages, and is involved in activation of ERK, JNK, and NF-kB, being required for secretion of TNF and nitric oxide. 38 We provide evidence that RasGEF1b is a TLRinducible gene with a potential function within inflammatory response. Future studies should provide new insights regarding the immunological functions of RasGEF1b.
Materials and methods
Cell culture, reagents, and antibodies HEK 293T, CHO cells, and murine macrophages were grown in 10% FBS DMEM medium supplemented with 2 mM L-glutamine, antibiotics (streptomycin, penicillin) at 37 1C in 5% CO 2 incubator. Escherichia coli LPS, polyriboinosinicpolycitidylic acid (poly I:C), and anti-FLAG M2 antibody were purchased from Sigma (Saint Louis, MO, USA). ODN CpG 5 0 -TCGTCGTTTTGTCGT-3 0 was purchased from Alpha DNA and Pam3cys from Alexis Biochemicals (Plymouth Meeting, PA, USA). Anti-calreticulin, anti-EEA1, and anti-LAMP1 were purchased from Abcam (Cambridge, MA, USA). Anti-Histone, anti-rab4, and anti-actin from Santa Cruz. Anti-Ras clone10 was purchased from Upstate (Billerica, MA, USA). ER Tracker, LysoTracker, Alexa Fluor 633 anti-rabbit IgG, Alexa Fluor 633 anti-rat IgG, and Alexa Fluor 488 anti-mouse IgG were purchased from Invitrogen (Carlsbad, CA, USA). Animals C57BL/6 female mice 6-8 weeks old were obtained from René Rachou Research Center, Oswaldo Cruz Foundation, grown under standard laboratory conditions with a 12 h-light/12 h-dark cycle and free access to food and water, and procedures performed after the institutional animal care guidelines. All knockout mice, MyD88-/-, TRIF-/, MAL/TIRAP-/-, and IFN-g-/-were provided by Federal University of Minas Gerais and treated the same way as mentioned earlier.
Isolation of peritoneal murine macrophages and treatments
Peritoneal cells were harvested from mice by washing the abdominal cavity with DMEM medium. The cells were centrifuged twice and suspended again in the same medium at a concentration of 1 Â 10 6 cells per ml. Peritoneal macrophages were obtained after 4 h of adhesion to plastic petri dishes (Nunc, Denmark) at 37 1C in an atmosphere of 5% CO 2 . To evaluate the message for RasGEF1b using the reverse transcriptase polymerase chain reaction (RT-PCR), peritoneal macrophages (1 Â 10 6 cells) were plated onto six-well plates and treated for 4 h with different TLR agonists, including ODN CpG (10 mM), LPS (1 mg ml -1 ), poly I:C (100 mg ml -1 ), and Pam3Cys (100 ng ml -1 ) or medium alone.
Total RNA extraction and RT-PCR analysis After treatments, medium was discarded and total RNA was obtained with Trizol following instructions of the manufacturer (Invitrogen). One microgram of total RNA was used to obtain the first strand cDNA in the presence of oligo-dT 15 0 -TATGTCGTGGAGTCTACT GGT-3 0 , and GAPDH reverse primer 5 0 -GAGTTGTC ATATTTCTCGTGG-3 0 . Levels of the mRNA for the housekeeping gene GAPDH were monitored in parallel to normalize the total amount of cDNA in each sample. The PCR products were fractionated onto 1.2% agarose gel, stained with ethidium bromide, visualized in UV transiluminator, and the images captured by a CCD camera.
Plasmids construction
For cloning of the amino-and carboxyl-terminus domains of RasGEF1b, two cDNA fragments of 501 and 920 base pairs encoding the amino-acids 1-167 and 168-473, respectively, were inserted into BamHI-EcoRI and EcoRI-SalI restriction sites of pGEX-5X-3 plasmid for the expression of GST-fusion-tagged protein. pFLAGRasGEF1b plasmid was obtained by ligation of a PCRamplified cDNA fragment of 1.4 kilobase pairs comprising the full coding sequence of amino-acids 1-473 of RasGEF1b in pCR4 vector (Sigma), and then a HindIIIHindIII fragment was subcloned in pFLAG-CMV2 vector (Sigma). pQERasGEF1b construct was generated by PCR amplification of mouse RasGEF1b cDNA, subcloned within pCR pCR2.1 TOPO (Invitrogen) vector and finally subcloned into SalI-HindIII sites of pQE-30 (Qiagen, Hilden, Germany). pcDNA3RasGEF1b-mRFP and pcDNA3RasGEF1b-YFP plasmids were generated by PCR amplification of pFLAG-RasGEF1b, subcloned into pCR2.1 TOPO, and finally subcloned within HindIIIEcoRI sites of pcDNA3-mRFP and pcDNA3-YFP, both kindly provided by Dr Douglas T Golenbock (UMass, USA). Endotoxin-free plasmids were prepared with the PureYieldTM plasmid midiprep system (Promega), according to the manufacturer's protocol.
Transfection of cells and immunoblotting analysis
The expression of GST-RasGEF1b-N (1-167 aa) and GSTRasGEF1b-C (168-473 aa) was obtained on induction of bacterial cell cultures with 1 mM isopropyl-1-thio-beta-Dgalactopyranoside for 4 h. Bacterial suspension was centrifuged at 5000 g for 20 min at 4 1C. Bacterial sediment was first resuspended in ice-cold PBS, after which was added vol/vol of 2 Â SDS protein loading buffer. Cell extracts were fractionated onto 10% SDS-PAGE, transferred to PVDF filter, and immunoprobed with anti-RasGEF1b antibody. Transfections of plasmids in 293T cells were performed by calcium phosphate method for all experiments. 39 The amount (in mg) of each transfected plasmid per well is shown in the figures. Briefly, after 48 h post-transfection, cells were first washed twice in PBS, and then lysed in lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, glycerol, and protease inhibitors cocktail). After Bradford assay, 30 mg of whole cell extract were fractionated onto 10% SDS-PAGE and detected by western blotting with the anti-FLAG. Bound antibodies were visualized with horseradish peroxidase-conjugated antirabbit or anti-mouse antibodies using a chemiluminescent substrate (ECL, Amersham, Piscataway, NJ, USA).
Cell fractionation
After 48 h post-transfection, cultures of 293T cells (1 Â 10 7 cells in 10 cm plate) were washed twice in ice-cold PBS. Cells were then lysed in a hypotonic buffer (20 mM HEPES-KOH, pH 7.5, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM EDTA, 0.2 mM PMSF, 1 mM dithiothreitol, 250 mM sucrose, 8 mg ml -1 aprotinin) and homogeneized on ice with a dounce homogeneizer. 293T cells were first centrifugated at 700 g for 10 min to pellet nuclei and cell debris (N). The saved supernatant was centrifuged at 10 000 g for 25 min to obtain the HM pellet. The supernatant obtained from the latter step was recentrifugated at 100 000 g to collect light membrane pellet and cytosolic supernatant.
Confocal microscopy
Transfection of plasmids in CHO cells were carried out using FuGENE 6 (Roche, Madison, WI, USA). Cells were grown on glass coverslips in complete media for 24 h and transfected with pcDNA3RasGEF1b-mRFP or pcDNA3RasGEF1b-YFP. After 48 h, cells were fixed with 4% paraformaldehyde/PBS for 20 min and permeabilized with 0.1% saponin. For live cell image, cells were selected for 3 days with G418 500 mg ml -1 . Primary antibodies were incubated at 4 1C overnight and fluorochrome-conjugated secondary antibodies were incubated for 1 h at room temperature. Acidic intracellular compartments and the endoplasmatic reticulum were stained with the acidophilic lysomotropic dye LysoTracker green or ER Tracker, respectively, according to the manufacturer's instructions. Confocal images were acquired using an LSM510 microscope and Carl Zeiss LSM Image software (Carl Zeiss Laser Scanning System, Oberkochen, Germany) for fixed cells, or an inverted Axiovert 100-M microscope equipped with a Zeiss LSM510 META scanning unit and a 1.4 NA 63 Â plan apochromat objective (Zeiss, Oberkochen, Germany), and an inverted Leica LSM TSC SP2 AOBS for live cell image.
Two-dimensional gel electrophoresis analysis
Peritoneal macrophages were harvested from mice, treated with LPS (1 mg ml -1 ) for 12 h, and lysed in a buffer containing urea 8M, thiourea 2M, CHAPs 4%, dithiothreitol 65 mM, Tris 40 mM, protease inhibitors, 2% ampholyte (pH ¼ 7-11), and trace bromophenol blue to obtain whole cell extract. Approximately 50 mg of protein extract was loaded onto no linear IPG strips (Bio-Rad, Hercules, CA, USA) 7 cm, covering a pH range of 7-11, were allowed to rehydrate in the above solution for 16 h at room temperature under mineral oil in the PROTEAN IEF Cell (Bio-Rad). The following voltage/time profile was used: 200 V for 1 h, 500 V for 1 h, 1000 V for 2 h, and a final phase of 8000 V until (accumulate 12000 V). After IEF, focused strips were equilibrated for 10 min in equilibration buffer (50 mM Tris-HCl, pH 8.8, 6M urea, 30% glycerol, and 2% SDS) containing 65 mM dithiothreitol. This was followed by 15 min incubation in equilibration buffer containing 135 mM iodoacetamide. The equilibrated strips were sealed to the top of the second-dimension gels using 0.5% agarose in running buffer. The second dimension was run in a 12% SDS-PAGE. The gels were stained by coomassie G-250 2% staining. Alternatively, the protein sample was transferred to a nitrocellulose membrane for western blotting. Images were captured by scanning the coomassie-stained gels, and then processed by PDquest 2D-image-analysis software (PDQUEST-7.3.0, Bio-Rad).
Co-immunoprecipitation and immunoblotting
The 293T cells, transfected or untransfected, were lysed in a Triton-containing lysis buffer. Cell extracts (0.5 mg) were mixed with 1 mg of anti-pan Ras antibody (sc-321, Santa Cruz Biotech) at 4 1C for 2 h. After this time, 25 ml of protein G sepharose beads (pre-washed and resuspended in PBS vol/vol) were added and incubated at 4 1C for 18 h. After incubation, the beads were washed three times in lysis buffer and twice in PBS, followed by 12% SDS-PAGE fractionation, transferring to PVDF membranes (Immobillon-P, Millipore, Billerica, MA, USA) and analysed by immunoblotting.
Ras activation assay
The activation of Ras was evaluated using a Ras activation assay kit according to the manufacturer's protocol. Briefly, HEK 293T cells were plated onto six-well plates and transfected with plasmid coding FLAGRasGEF1b or RasGEF1b-mRFP. Twenty four hours later, cells were lysed with 500 ml of Mg 2 þ lysis/wash buffer. As a positive and negative control, GTPgS or GDP 100 Â , respectively, was added to lysate. Then, Raf-1 Ras-binding domain-conjugated agarose was added to the lysate, and it was incubated at 4 1C for 30 min. Raf-1 Ras-binding domain -conjugated agarose is a glutathione S-transferase-fusion protein, corresponding to the human Ras-binding domain (residues 1-149) of Raf-1, provided bound to glutathione-agarose; it specifically binds to and precipitates Ras-GTP from cell lysates. After washing the beads three times with Mg 2 þ lysis/wash buffer, they were suspended in 2 Â Laemmli sample buffer, subjected to SDS-PAGE and immunoblot analysis using anti-Ras10 as a primary antibody, and visualized using the ECL western blotting detection system.
Preparation of anti-His6RasGEF1b polyclonal antibody
Polyclonal rabbit anti-RasGEF1b serum was raised against a recombinant protein His6-RasGEF1b. It was expressed in E. coli for 4 h, purified from insoluble fraction and then injected subcutaneously into two New Zealand White rabbits emulsified with an equal volume of Freund complete adjuvant (Sigma)/protein in the first immunization, or Freund incomplete adjuvant (Sigma) in the three after immunizations. We used 300 mg of purified His6-RasGEF1b in each immunization. After confirming an increase in the levels of antibody titer by ELISA, the whole blood was collected from each rabbit and the serum was separated.
Three-dimensional model
The molecular model of RasGEF1b was built using the homology-modelling program ESyPred3D 40 that is based on a strategy using neural networks to evaluate sequence alignments. ESyPred3D uses the program MODELLER to build the final structural model. The 3D model of RasGEF1b was based on the crystal structure of the GEF region of human Sos1, chain S, in PDB structure 1bkd. 41 The program PyMOL (http://pymol.sourceforge.net/) was used to visualize the models.
